Showing 571-580 of 3024 results for "".
News
https://practicalneurology.com/columns/practice-management/news/30585/Genetically Targeted Therapies for Inherited Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetically-targeted-therapies-for-inherited-neuromuscular-disorders/31816/Targeted genetic therapies for neuromuscular disorders have ushered in a new era with still unresolved clinical, ethical, and economic questions to address.Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis/31814/More treatments for myasthenia gravis are on the way.Innovations in Functional Imaging of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/innovations-in-functional-imaging-of-epilepsy/30317/Advances in noninvasive imaging should create more opportunities for physicians to localize treatment and optimize care.Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: Current Landscape and Potential Utility in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/blood-and-cerebrospinal-fluid-biomarkers-in-amyotrophic-lateral-sclerosis-current-landscape-and-potential-utility-in-clinical-practice/35542/Amyotrophic lateral sclerosis biomarkers are increasingly shaping the development of new treatments.Identification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/identification-management-and-prevention-of-polypharmacy-in-multiple-sclerosis/32088/Rational prescription practices in multiple sclerosis treatment are key to the prevention and mitigation of polypharmacy.Multiple Sclerosis in the Black Population of the United States
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-black-population-of-the-united-states/31756/Black people with multiple sclerosis are affected by frequent relapses, early disability accrual, and rapid disease progression.Sphingosine-1-Phosphate Modulators for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/sphingosine-1-phosphate-modulators-for-multiple-sclerosis/31629/Sphingosine-1-phosphate modulators may act through more than just inhibition of neuroimmune and neuroinflammatory effects of multiple sclerosis.Movement Disorders Moment: Comprehensive Care in Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-comprehensive-care-in-movement-disorders/32034/Building a team to address all aspects of movement disorders care is crucial for maximixing patient care and quality of life.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31327/Thousands of neurologists gathered at the San Diego Convention Center from April 1-8 for the American Academy of Neurology’s (AAN) annual conference, fostering extensive collaboration across subspecialties. Among the key highlights were the release of four new evidence-based practice parameters for